Hem › Major depression › Alabama
Kliniska studier för Major depression i Alabama
15 studier för Major depression söker deltagare vid platser i Alabama.
Städer i Alabama
Officiell studietext (engelska)
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- University of Alabama at Birmingham - School of Medicine, Birmingham
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 1 okt. 2026 · NCT07775300Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- University of Alabama at Birmingham, Huntsville
RekryterarFas 3
Ålder 18 till 65 · Alla kön · Uppdaterad 25 sep. 2026 · NCT05850689A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- University of Alabama at Birmingham, Birmingham
RekryterarFas 3
Ålder 12 till 17 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07227454A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- UAB Psychiatry and Behavioral Neurology, Birmingham
RekryterarFas 3
Ålder 18 till 85 · Alla kön · Uppdaterad 25 sep. 2026 · NCT06793397A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- University of Alabama at Birmingham, Huntsville Regional Medical Campus, Huntsville
RekryterarFas 3
Ålder 18 till 74 · Alla kön · Uppdaterad 8 sep. 2026 · NCT07076407Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- University of Alabama at Birmingham - Dept. of Psychiatry, Birmingham
Rekryterar
Ålder 22 till 70 · Alla kön · Uppdaterad 28 aug. 2026 · NCT06423430Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
- Birmingham VA Medical Center, Birmingham, AL, Birmingham
- Tuscaloosa VA Medical Center, Tuscaloosa, AL, Tuscaloosa
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 14 aug. 2026 · NCT07226232NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Huntsville
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 11 aug. 2026 · NCT06911112Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- University of Alabama at Birmingham, Birmingham
RekryterarFas 2
Ålder 18 till 64 · Alla kön · Uppdaterad 3 aug. 2026 · NCT06547489Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Huntsville
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 24 juli 2026 · NCT06966401Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents
- University of Alabama at Birmingham, Birmingham
- UAB Huntsville Regional Medical Campus, Huntsville
RekryterarFriska volontärer välkomna
Ålder 10 till 24 · Alla kön · Uppdaterad 13 juli 2026 · NCT05437588A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Harmonex /ID# 277517, Dothan
RekryterarFas 2
Ålder 18 till 65 · Alla kön · Uppdaterad 15 juni 2026 · NCT07276997MicroRNA Correlates of Childhood Maltreatment and Suicidality
- University of Alabama at Birmingham, Birmingham
- UAB Huntsville Regional Medical Campus, Huntsville
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 18 till 60 · Alla kön · Uppdaterad 30 mars 2026 · NCT04923685Using TMS to Understand Neural Processes of Social Motivation
- Auburn University, Auburn
Rekryterar
Ålder 25 till 50 · Alla kön · Uppdaterad 3 mars 2026 · NCT06274112Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #131, Birmingham
RekryterarFas 2
Ålder 18 till 65 · Alla kön · Uppdaterad 20 jan. 2026 · NCT06633016Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.